Peter Bains, Director& CEO, Syngene International LTD & Kiran Muzumdar Shaw, MD, Syngene International LTD addresses during the press conference to announce Initial Public offer in Mumbai on Thursday, 16 July 2015. Pharmaceutical company Biocon Ltd has fixed a price band for an initial public offering (IPO) of its subsidiary Syngene International Ltd at Rs.240-250 per equity share.
Tags: Director and Chief Executive Officer at Syngene International LimitedDirector at Syngene International Limitedhorizontal
Credit balance: 0